oxidopamine has been researched along with Sensation Disorders in 4 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Sensation Disorders: Disorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baufreton, J | 1 |
| Milekovic, T | 1 |
| Li, Q | 1 |
| McGuire, S | 1 |
| Moraud, EM | 1 |
| Porras, G | 1 |
| Sun, S | 1 |
| Ko, WKD | 1 |
| Chazalon, M | 1 |
| Morin, S | 1 |
| Normand, E | 1 |
| Farjot, G | 1 |
| Milet, A | 1 |
| Pype, J | 1 |
| Pioli, E | 1 |
| Courtine, G | 1 |
| Bessière, B | 1 |
| Bezard, E | 1 |
| Reyes, S | 1 |
| Mitrofanis, J | 1 |
| Fleming, SM | 1 |
| Schallert, T | 1 |
| Ciucci, MR | 1 |
| Tassorelli, C | 1 |
| Armentero, MT | 1 |
| Greco, R | 1 |
| Fancellu, R | 1 |
| Sandrini, G | 1 |
| Nappi, G | 1 |
| Blandini, F | 1 |
1 review available for oxidopamine and Sensation Disorders
| Article | Year |
|---|---|
Cranial and related sensorimotor impairments in rodent models of Parkinson's disease.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Disease Models, Animal; Feeding Behavior; Mice; M | 2012 |
3 other studies available for oxidopamine and Sensation Disorders
| Article | Year |
|---|---|
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism.
Topics: Administration, Inhalation; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Rel | 2018 |
Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats.
Topics: Animals; Disease Models, Animal; Functional Laterality; Immunohistochemistry; Lumbar Vertebrae; Male | 2008 |
Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Biomarkers; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Hyp | 2007 |